Square Pharmaceuticals (DHA:SQURPHARMA) Operating Cash Flow per Share : BDT15.71 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Operating Cash Flow per Share?

Square Pharmaceuticals's operating cash flow per share for the three months ended in Dec. 2023 was BDT5.05. Square Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT15.71.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Square Pharmaceuticals was 30.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -7.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Square Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

DHA:SQURPHARMA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -49.9 Med: 5.75 Max: 28.7
Current: -7.4

During the past 13 years, Square Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.70% per year. The lowest was -49.90% per year. And the median was 5.75% per year.

DHA:SQURPHARMA's 3-Year OCF Growth Rate is ranked worse than
70.22% of 806 companies
in the Drug Manufacturers industry
Industry Median: 8.1 vs DHA:SQURPHARMA: -7.40

Square Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Square Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Operating Cash Flow per Share Chart

Square Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

13.98

12.14

12.38

14.52

9.64

Square Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															2.58	2.65	-1.31	9.33	5.05

Competitive Comparison of Square Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Square Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Square Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Square Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Square Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Square Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Square Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	8545.614	/	886.451
	=	9.64

Square Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	4471.205	/	885.977
	=	5.05

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT15.71

Square Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Square Pharmaceuticals (DHA:SQURPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212

Website

http://www.squarepharma.com.bd

Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.

Square Pharmaceuticals (DHA:SQURPHARMA) Headlines

No Headlines